How the public sector is working with private firms to fight COVID-19

How the public sector is working with private firms to fight COVID-19
Shortly after the World Health Organization learned of “a pneumonia of unknown cause … in Wuhan, China,” leading U.S. research firms started working around the clock to learn more about the novel coronavirus. In just three months, dozens of promising treatments and vaccines have entered the pipeline. Some are already in human trials.

This record-breaking pace is thanks, in part, to the dedicated efforts of America’s biopharmaceutical industry. Every day, our nation’s scientists research treatments for various diseases. That’s why the government can count on them in times of crisis.  

On March 24-25, I tuned in for a virtual summit hosted by the Biotechnology Innovation Organization, where industry leaders and senior government officials discussed the many ways they’re already working together to fast-track a cure. Participants also brainstormed other ways they might be able to cooperate.  

 
Sign Up for Our Email Newsletter

RECENT NEWS

Pfizer eyes FDA emergency approval for vaccine by this month

Pfizer eyes FDA emergency approval for vaccine by this month

Former U.S. FDA Associate Commissioner Peter Pitts discusses Pfizer COVID vaccine ...  Read more

Why Pfizer's COVID-19 Vaccine Trial Is Being Called a ‘Game-Changer' for the Pandemic

Why Pfizer's COVID-19 Vaccine Trial Is Being Called a ‘Game-Changer' for the Pandemic

Pfizer has released early data that shows its COVID-19 vaccine is more than 90% effective. Former FDA Associate Commissio...  Read more

World Health Organization: 70 COVID-19 Vaccines Under Development, With 3 In Human Trials

World Health Organization: 70 COVID-19 Vaccines Under Development, With 3 In Human Trials

Peter Pitts on Fox News Channel with Neil Cavuto "World Health Organization: 70 COVID-19 Vaccines Under Development, Wi...  Read more

DRUGWONKS BLOG